Global Review of Intellectual Property (IP) Funds

Global Review of Intellectual Property (IP) Funds

RELEASE DATE
29-Sep-2015
REGION
Global
Research Code: D61C-01-00-00-00
SKU: LS00083-GL-MR_16924
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
LS00083-GL-MR_16924

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

Introduction of a system of IP funds, patent funds or patent value funds in various IP conscious countries has been a recent development. This market insight provides an overview of various IP fund related initiatives undertaken by Taiwan, Japan, South Korea and China.

Table of Contents

Global Review of Intellectual Property (IP) Funds

  • Analysis of Intellectual Property (IP) Funds
Related Research
Big pharma companies increasingly consider outsourcing manufacturing to CMOs as a strategic move because of the uncomplicated, timely, and cost-effective services CMOs provide as well as the fact that companes can then focus on their core competencies. This study provides market overview, market engineering measurements, revenue forecasts, competitive analysis, and key trends for the pharmaceutical contract manufacturing market and its segments. Regional analysis includes The United States, European countries such as the United Kingdom, Germany, France, Italy, Spain, Benelux, Scandinavia, and Rest of World are covered. The period covered in the study is from 2009 to 2017, with the base year of 2012.
More Information
No Index No
Podcast No
Author Sudeep Basu
WIP Number D61C-01-00-00-00
Is Prebook No